梯瓦制药在华盛顿联邦法院对IRA药品定价法案的挑战败诉
Teva loses IRA drug pricing challenge in DC federal court
#federal court#loses IRA#IRA drug#Medicare negotiations#pharma industry
生命科学资讯
生物技术与制药领域的最新动态
交易快讯：雅培、TPG与龙沙集团大举行动，M&M乳业及新堡垒能源遇挫——Benzinga报道
Deal Dispatch: Abbott, TPG And Lonza Make Major Moves, M&M Custard And New Fortress Energy Struggle - Benzinga
#Major Moves#Lonza Make#Make Major#Fortress Energy#Energy Struggle
Why is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? (Thermo Fisher TMO)
Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? - Yahoo Finance
#Thermo Fisher#Earnings Report#TMO#Yahoo Finance#Fisher
🚀 Here is the translation of the title to Simplified Chinese: 赛瑞塔公司终止Elevidys试验； Moderna部分pipeline项目被砍 Please note that pre-treatment is not explicitly translated in the title, as it is a concept rather than a specific term.
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
#Blue Lake#Inhibikase Therapeutics#Olema Oncology#Elevidys trial#Hansa Biopharma
FDA調查可能與Takeda的酶替代療法相關的兒童死亡事件
FDA investigates child death potentially related to Takeda's enzyme replacement therapy
#FDA investigates#blood disorder#Takeda enzyme#potentially related#investigates child
诺瓦、利利开始直接向雇主销售肥胖药物
Novo, Lilly begin to sell obesity medications directly to employers
#Novo Nordisk#Eli Lilly#employers Building#Lilly begin#weight loss
罗氏签署2亿美元协议，引进Freenome癌症筛查血液检测技术——Fierce Biotech报道
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
#Fierce Biotech#Freenome cancer#Roche inks#cancer screening#screening blood
( Lǐ Lǐ chéng wéi dì yī jiǔ qiān yào yè gōng sī )
Lilly becomes first $1 trillion pharma company
#Eli Lilly#company Eli#Lilly market#pharma company#briefly reached
Contineum与强生合作药物在多发性硬化症二期试验中失败
Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial
#Thursday afternoon#fails Phase#Therapeutics reported#multiple sclerosis#J-partnered drug
光通信公司增持安捷伦科技股份$A - MarketBeat
Hikari Tsushin Inc. Raises Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
#Agilent Technologies#Hikari Tsushin#Stock Holdings#Raises Stock#Tsushin
安捷伦科技财报前瞻：Benzinga解读市场预期
What to Expect from Agilent Technologies's Earnings - Benzinga
#Agilent Technologies#Technologies Earnings#Earnings Benzinga#Expect#Agilent
安捷伦科技公司（NYSE:A）宣布提高股息至每股0.26美元——MarketBeat报道
Agilent Technologies, Inc. (NYSE:A) to Issue Dividend Increase - $0.26 Per Share - MarketBeat
#Agilent Technologies#Dividend Increase#Issue Dividend#NYSE#Technologies
先锋集团增持安捷伦科技股份589,219股 $A - MarketBeat
Vanguard Group Inc. Buys 589,219 Shares of Agilent Technologies, Inc. $A - MarketBeat
#Agilent Technologies#Vanguard Group#Group#Shares#Technologies
Primecap Management Co. CA持有安捷伦科技公司$A股份价值1.8069亿美元——MarketBeat报道
Primecap Management Co. CA Has $180.69 Million Stake in Agilent Technologies, Inc. $A - MarketBeat
#Million Stake#Agilent Technologies#Primecap Management#Million#Technologies
葛兰素史克与阿纳普蒂生物就十年期Jemperli许可协议对簿公堂
GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal
#decade-old Jemperli#drug Jemperli#Jemperli licensing#subsidiary Tesaro#cancer drug
艾利利 Laboratories 成为第一家价值一万亿美元的制药公司
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
#Eli Lilly#drugmaking peers#pharmaceutical company#success developing#developing medicines
沃特世公司股票：华尔街看涨还是看跌？- Barchart.com
Waters Corporation Stock: Is Wall Street Bullish or Bearish? - Barchart.com
#Corporation Stock#Wall Street#Street Bullish#Waters Corporation#Stock
杰夫·布鲁斯通与斯蒂芬·迪利探讨CEO交接及索诺玛未来走向；斯科特·戈特利布的下一步动向
Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb's next move
#Stephen Dilly#Scott Gottlieb#Jeff Bluestone#Sonoma Biotherapeutics#CEO handoff
FDA 探索加速药物制造商谈判的新计划；Bezos关联AI初创公司筹集6000万美元
FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M
#quick clarifications#FDA tests#drugmaker talks#speed drugmaker#agency staff
野村资产管理有限公司购入安捷伦科技公司A股股份 - MarketBeat报道
Agilent Technologies, Inc. $A Shares Purchased by Nomura Asset Management Co. Ltd. - MarketBeat
#Agilent Technologies#Shares Purchased#Nomura Asset#Asset Management#Technologies